BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Aptamer Group Licenses Optimer Binder To Alphazyme For Hot Start PCR Applications

-Exclusive OEM license grants worldwide rights for Optimer® binder in molecular biology applications Royalty structure includes product sales, milesto...

December 31, 2025 | News

Sobi Secures Positive CHMP Opinion For Aspaveli In Rare Kidney Diseases

Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN If approved, Aspaveli (pegcetacoplan) would be the first C3G and primary IC-...

December 30, 2025 | News

EMA CHMP Backs Gotenfia Golimumab Biosimilar Advancing STADA and Bio Thera European Strategy

Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marke...

December 30, 2025 | News

Italfarmaco Partners With JCR Pharmaceuticals To Advance Givinostat Development And Commercialisation In Japan

Italfarmaco grants JCR Pharmaceuticals exclusive rights to develop and commercialise givinostat in Japan - - Additional strategic collaboration in rare ...

December 25, 2025 | News

Bioeq And Zydus Secure USFDA Approval For Interchangeable Lucentis Biosimilar NUFYMCO

Bioeq AG ("Bioeq"), a Swiss biopharmaceutical company, and Zydus Lifesciences Limited ("Zydus"), an innovation-led life-sciences company with an internatio...

December 24, 2025 | News

Merck Secures World First Regulatory Approval For Pimicotinib In Rare Joint Tumour TGCT In China

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantl...

December 23, 2025 | News

UK Hospitals Adopt AI Tool MEMORI To Strengthen Early Detection Of Hospital Acquired Infections

Sanome, the health tech company behind MEMORI, an AI-powered clinical decision support tool that helps clinicians detect hospital-acquired infections (HAIs...

December 18, 2025 | News

Sobi To Acquire Arthrosi Therapeutics In Up To $1.5 Billion Deal

Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which w...

December 16, 2025 | News

Neurimmune And Alexion Expand Global Collaboration To Advance NI009 For Light Chain Amyloidosis

Neurimmune announced that it has expanded on its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, AstraZeneca Rare Disease ...

December 05, 2025 | News

Samsung Bioepis Gains CHMP Backing for BYOOVIZ Pre Filled Syringe

European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for BYOOVIZ® (ranibizuma...

December 03, 2025 | News

NADMED Launches Global Award to Unlock the Secrets of Cellular Redox Metabolism

As scientists seek to understand the molecular basis of energy production, aging, and disease, one area remains especially elusive: cellular redox metaboli...

December 03, 2025 | News

Oxford Instruments Launches Imaris 11 for Next Level Microscopy Analysis

Oxford Instruments announces the release of Imaris 11, the latest generation of its industry-leading 3D/4D microscopy image visualisation and analysis...

December 02, 2025 | News

BioDlink Drives Global Biologics Innovation with World’s First Approved EGFR-Targeted ADC

Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyng...

December 01, 2025 | News

Teijin Pharma to Receive $5M Milestone as Bioprojet Advances Novel Narcolepsy Candidate to Phase 1

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that it will receive in Q4 2025 a milestone paym...

November 28, 2025 | News

Stay Connected